Clinical Trials Browser

INDUSTRY × efineptakin alfa × CNS × Clear all

NCT05191784 2023-06-12

GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients

Phase 2 Unknown

Glioblastoma

NCT04065087 2022-03-17

Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Withdrawn

Newly Diagnosed Glioblastoma

NCT04289155 2022-03-17

Individual Patient Compassionate Use of GX-I7

No longer available

CNSDermatologic

Glioblastoma, Glioma, Melanoma